![]() |
BeijingMay 31, 2026 /PRNewswire/ — iHuman Inc. (NYSE: IH) (“iHuman” or the “Company”), a leading Chinese technology-enabled education and entertainment products company, today announced that it has entered into an asset transfer agreement to acquire the business and assets related to two products, Quanzhishi and Wanciwang (the “Acquisition”), for a total consideration of RMB 94 million, subject to potential bilateral price adjustment mechanisms and additional contingent consideration.
Quanzhishi is an application focused on humanities knowledge and AI general education, offering users an AI-powered interactive learning experience covering history, culture, literature, philosophy, art, and other humanities fields. It features multiple systematic learning tools, including a time-space pillar, historical timeline, and relationship graph, and has successfully launched a series of ladder learning products. Among them, the Elite Youth Ladder is one of the first systematic general education learning products in China, the Humanities Ladder provides comprehensive and structured humanities learning content for enthusiasts, and the AI Ladder aims to help learners fully apply, understand, and master AI.
Wanciwang is a tool-based AI learning application designed to help learners improve their vocabulary and pronunciation skills, and unlock comprehensive English learning abilities, through real-person video-based learning, rich word resources, AI assessments, in-depth training and pronunciation practice, and a personalized AI learning system centered on vocabulary.
Mr. Yufeng Chi, Founder and Chairman of iHuman, stated: “We are pleased to announce the acquisition of the business and assets related to Quanzhishi and Wanciwang. This acquisition not only represents a significant step in expanding our product portfolio but also marks a strategically crucial move in our industry. The strong content, AI technology advantages, understanding of the all-age learning market, and organizational execution in sales services of Quanzhishi and Wanciwang are highly complementary to our existing product ecosystem, opening up new market opportunities for us. Quanzhishi and Wanciwang will also help us extend our service boundaries and reach, further broadening our product layout and AI technology boundaries, deepening content offerings, enriching product tiers, and creating stronger synergies among our products. This move will greatly enhance our market competitiveness and bring tremendous potential for future growth.
At the same time, on behalf of the Company’s Board of Directors, I am pleased to announce the appointment of Mr. Teng Li, from Quanzhishi and Wanciwang, as Co-CEO of iHuman, effective upon the closing of the transaction. Additionally, to meet the Company’s business development needs, we warmly welcome Ms. Congyu Lin to iHuman as Chief Strategy Officer (CSO). Prior to joining iHuman, Ms. Lin served as Senior Vice President at Perfect World, bringing extensive management and strategic planning experience. Mr. Teng Li and Ms. Congyu Lin have demonstrated outstanding leadership and deep professional expertise in their respective fields. Their addition will inject new vitality and strategic vision into iHuman. We firmly believe they will work closely with the existing management team to drive the Company’s business development, open up broader market spaces, and create more sustainable growth momentum.” Mr. Chi concluded.
According to the asset transfer agreement, the Company will acquire the business and assets related to Quanzhishi and Wanciwang, with consideration of RMB 67 million and RMB 27 million, respectively, subject to potential price adjustment mechanisms. In the event of certain material adverse events, the purchase price will be reduced to RMB 51 million for Quanzhishi and RMB 21 million for Wanciwang. Additionally, the seller is entitled to receive additional cash consideration of up to RMB 29 million (for Quanzhishi) and RMB 12 million (for Wanciwang), based on the achievement of agreed performance targets over the next three years.The Company engaged a “Big Four” accounting firm (the “Appraiser”) to provide valuation services and prepare an independent third-party valuation. The relevant consideration was determined with the assistance of the Appraiser. Given that the transferor and the Company are under common control, the Acquisition constitutes a related party transaction, which has been approved by the Company’s Board of Directors and Audit Committee, and is subject to customary closing conditions. The appointments of Mr. Teng Li and Ms. Congyu Lin have also been nominated by the Company’s Nominating and Corporate Governance Committee and formally approved by the Board of Directors.
Safe Harbor Statement
This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar statements. All statements other than statements of historical fact, including statements regarding iHuman’s beliefs and expectations, are forward-looking statements. In addition, descriptions of management’s statements in this announcement contain forward-looking statements, and iHuman may make oral or written forward-looking statements in its periodic reports filed with the U.S. Securities and Exchange Commission, annual reports to shareholders, press releases, and other written and oral statements made by officers, directors, or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. Several important factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman’s development strategies; future business development, financial condition, and results of operations; iHuman’s ability to continue to attract and retain users, convert non-paying users into paying users, and increase paying user spending; trends and scale of the markets for iHuman’s products; iHuman’s expectations regarding market demand and market acceptance of its products and services; iHuman’s expectations regarding its relationships with business partners; general economic and business conditions; the regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman’s filings with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this release. iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.
About iHuman Inc.
iHuman Inc. is a leading Chinese technology-enabled education and entertainment products company. The Company is dedicated to making parenting easier and children’s growth happier. Benefiting from nearly three decades of experience in the parent-child industry, outstanding original content, advanced technological innovation, and deep research and development capabilities, iHuman provides parents with efficient parent-child companionship resources and inspires children’s natural curiosity and desire for exploration through unique and engaging interactive product experiences. iHuman’s innovative, high-quality, and diverse products, including interactive apps, interactive content, and smart devices, cover a wide range of thematic content, cultivating children’s language skills, logical thinking, reading ability, and creativity. Leveraging its unique and advanced technical capabilities in 3D engines, AI/AR interaction, and big data analysis of children’s behavior and psychology, iHuman will continue to provide high-quality technology-enabled education and entertainment products, offering efficient, easy, and high-quality parenting experiences for parents in China and around the world, and embarking on a fulfilling and enjoyable growth journey for children.
Contact:

